Search Results

Editorial [ Neuropeptide Y Receptors as Targets in Drug Discovery Guest Editor: Ambikaipakan Balasubramaniam ]

Author: Balasubramaniam, Ambikaipakan

Source: Current Topics in Medicinal Chemistry, Volume 7, Number 17, September 2007 , pp. 1644-1644(1)

Publisher: Bentham Science Publishers

NPY and Cardiac Diseases

Authors: McDermott, B. J.; Bell, D.

Source: Current Topics in Medicinal Chemistry, Volume 7, Number 17, September 2007 , pp. 1692-1703(12)

Publisher: Bentham Science Publishers

NPY Family of Hormones: Clinical Relevance and Potential Use in Gastrointestinal Disease

Authors: Vona-Davis, L. C.; McFadden, D. W.

Source: Current Topics in Medicinal Chemistry, Volume 7, Number 17, September 2007 , pp. 1710-1720(11)

Publisher: Bentham Science Publishers

Peptide YY(1-36) and Peptide YY(3-36): Part I. Distribution, Release and Actions

Author: Ballantyne, Garth

Source: Obesity Surgery, Volume 16, Number 5, May 2006 , pp. 651-658(8)

Publisher: Springer

Neuropeptide Y receptors as targets of obesity treatment

Authors: Ishihara PhD, Akane; Moriya PhD, Minoru; MacNeil PhD, Douglas J; Fukami PhD, Takehiro; Kanatani PhD, Akio

Source: Expert Opinion on Therapeutic Patents, Volume 16, Number 12, December 2006 , pp. 1701-1712(12)

Publisher: Informa Healthcare

CCK and NPY as anti-anxiety treatment targets: promises, pitfalls, and strategies

Author: Harro, J.

Source: Amino Acids, Volume 31, Number 3, October 2006 , pp. 215-230(16)

Publisher: Springer

Neuropeptide Y-family receptors Y₆ and Y₇ in chicken: Cloning, pharmacological characterization, tissue distribution and conserved synteny with human chromosome region

Authors: Bromée, Torun; Sjödin, Paula; Fredriksson, Robert; Boswell, Tim; Larsson, Tomas A.; Salaneck, Erik; Zoorob, Rima; Mohell, Nina; Larhammar, Dan

Source: FEBS Journal, Volume 273, Number 9, May 2006 , pp. 2048-2063(16)

Publisher: Blackwell Publishing

NPY Receptors as Drug Targets for the Central Regulation of Body Weight

Authors: Feletou, Michel; Galizzi, Jean-Pierre; Levens, Nigel R.

Source: CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets, Volume 5, Number 3, June 2006 , pp. 263-274(12)

Publisher: Bentham Science Publishers

Neuropeptide Y inhibits acetylcholine release in human heart atrium by activation of Y₂-receptors

Authors: Schwertfeger, Eckhard; Klein, Thomas; Vonend, Oliver; Oberhauser, Vitus; Stegbauer, Johannes; Rump, Lars

Source: Naunyn-Schmiedeberg's Archives of Pharmacology, Volume 369, Number 5, May 2004 , pp. 455-461(7)

Publisher: Springer

Functional autoradiography of neuropeptide Y Y1 and Y2 receptor subtypes in rat brain using agonist stimulated [³⁵S]GTPS binding

Authors: Shaw J.L.; Gackenheimer S.L.; Gehlert D.R.

Source: Journal of Chemical Neuroanatomy, Volume 26, Number 3, November 2003 , pp. 179-193(15)

Publisher: Elsevier

Cloning, pharmacology, and distribution of the neuropeptide Y-receptor Yb in rainbow trout

Authors: Larson E.T.; Fredriksson R.; Johansson S.R.T.; Larhammar D.

Source: Peptides, Volume 24, Number 3, March 2003 , pp. 385-395(11)

Publisher: Elsevier

Pharmacological characterization of cloned chicken neuropeptide Y receptors Y₁ and Y₅

Authors: Holmberg, Sara K. S.; Mikko, Sofia; Boswell, Timothy; Zoorob, Rima; Larhammar, Dan

Source: Journal of Neurochemistry, Volume 81, Number 3, May 2002 , pp. 462-471(10)

Publisher: Blackwell Publishing

Neuropeptide Y receptor subtypes in the basolateral nucleus of the amygdala modulate anxiogenic responses in rats

Authors: Sajdyk T.J.; Schober D.A.; Gehlert D.R.

Source: Neuropharmacology, Volume 43, Number 7, December 2002 , pp. 1165-1172(8)

Publisher: Elsevier

Differential changes in messenger RNA expressions and binding sites of neuropeptide Y Y₁, Y₂ and Y₅ receptors in the hippocampus of an epileptic mutant rat: Noda epileptic rat

Authors: Jinde S.; Masui A.; Morinobu S.; Noda A.; Kato N.

Source: Neuroscience, Volume 115, Number 4, 16 December 2002 , pp. 1035-1045(11)

Publisher: Elsevier

Neuropeptide Y and its receptors as potential therapeutic drug targets

Authors: Silva A.P.; Cavadas C.; Grouzmann E.

Source: Clinica Chimica Acta, Volume 326, Number 1, December 2002 , pp. 3-25(23)

Publisher: Elsevier

Novel neuropeptide Y1 and Y5 receptor gene variants: associations with serum triglyceride and high-density lipoprotein cholesterol levels

Authors: Blumenthal J.; Andersen R.; Mitchell B.; Seibert M.; Yang H.; Herzog H.; Beamer B.; Franckowiak S.; Walston J.

Source: Clinical Genetics, Volume 62, Number 3, September 2002 , pp. 196-202(7)

Publisher: Blackwell Publishing

The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y

Authors: Kask A.; Harro J.; von Horsten S.; Redrobe J.P.; Dumont Y.; Quirion R.

Source: Neuroscience and Biobehavioral Reviews, Volume 26, Number 3, May 2002 , pp. 259-283(25)

Publisher: Elsevier

Clinical potentials of neuropeptide Y family of hormones

Author: Balasubramaniam A.

Source: The American Journal of Surgery, Volume 183, Number 4, April 2002 , pp. 430-434(5)

Publisher: Elsevier

Activation of extracellular signal regulated protein kinase by neuropeptide Y and pancreatic polypeptide in CHO cells expressing the NPY Y₁, Y₂, Y₄ and Y₅ receptor subtypes

Authors: Mullins D.E.; Zhang X.; Hawes B.E.

Source: Regulatory Peptides, Volume 105, Number 1, 15 April 2002 , pp. 65-73(9)

Publisher: Elsevier

A neuropeptide Y receptor Y1-subfamily gene from an agnathan, the European river lamprey: A potential ancestral gene

Authors: Salaneck, Erik; Fredriksson, Robert; Larson, Earl T.; Conlon, J. Michael; Larhammar, Dan

Source: FEBS Journal, Volume 268, Number 23, 2001December 2001 , pp. 6146-6154(9)

Publisher: Blackwell Publishing